Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1192 |
Phytochemical name or plant extracts |
Tamarix aphylla essential oil |
PMID |
30034503 |
Literature evidence |
In vitro screening of potential cytotoxicity of the aqueous (AE) and ethanol (EE) extracts was also evaluated against human breast adenocarcinoma (MCF-7), colorectal adenocarcinoma (Caco-2), and pancreatic carcinoma (Panc-1) cancer cell lines as well as normal human fibroblasts. |
IUPAC name |
NA |
Phytochemicals’ class or type of plant extracts |
Essential oil, Aqueous extract, Ethanolic extract |
Source of phytochemicals or plant Extracts |
Tamarix aphylla |
|
Geographical availability |
Afghanistan, Algeria, Chad, Djibouti, Egypt, Eritrea, Ethiopia, Gulf States, India, Iran, Iraq, Kenya, Kuwait, Libya, Mauritania, Morocco, Niger, Oman, Pakistan, Palestine, Saudi Arabia, Senegal, Sinai, Socotra, Somalia, Sudan, Tunisia, Yemen |
Plant parts |
Aerial parts |
Other cancers |
Breast cancer, Colorectal cancer, Pancreatic cancer |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
NA |
IC50 |
Aqueous extract - 2.17 ± 0.10 μg/mL against MCF-7
Ethanol extract - 26.65 ± 3.09 μg/mL against MCF-7 |
Potency |
The data obtained in this study suggest that diferent extracts of T. aphylla have potential antiproliferative activities against MCF-7 cancer cell line, which could be a source of promising lead compounds for the development of new treatments for some cancer types. |
Cell line/ mice model |
MCF-7, Caco-2, Panc-1 |
Additional information |
In Saudi Arabia, alcohol extract from leaves of T.
aphylla was shown to possess antioxidant, anti-inflammatory, and wound-healing activities. |
PubChem ID |
NA |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:828051-1 |
Safety |
NA |